Benzenesulfonamides
eMolecules 138-41-0 | 4-Carboxybenzenesulfonamide | Combi-Blocks | MFCD00007938 | 201.200 | C7H7NO4S | 97.000 | NS(=O)(=O)c1ccc(cc1)C(O)=O | 5g | 290689617
4-Carboxybenzenesulfonamide | Combi-Blocks | 138-41-0 | MFCD00007938 | 201.200 | C7H7NO4S | 97.000 | NS(=O)(=O)c1ccc(cc1)C(O)=O | 5g | 290689617
eMolecules 106058-86-0 | N-Tosyl-3-pyrrolecarboxylic acid | Combi-Blocks | MFCD00145013 | 265.280 | C12H11NO4S | 96.000 | Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)C(O)=O | 5g | 205390403
N-Tosyl-3-pyrrolecarboxylic acid | Combi-Blocks | 106058-86-0 | MFCD00145013 | 265.280 | C12H11NO4S | 96.000 | Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)C(O)=O | 5g | 205390403
Medchemexpress LLC HY-19794 5mg Medchemexpress, MP-A08 CAS:219832-49-2 Purity:>98%
Medchemexpress, HY-19794 5mg MP-A08 CAS:219832-49-2 MP-A08 is a highly selective ATP competitive sphingosine kinase (SPHK1) inhibitor that targets both SphK1 and SphK2 with Ki values of 6.9 ± 0.8 μM and 27 ± 3 μM, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![eMolecules 171599-83-0 | Sildenafil citrate | Target Molecule | MFCD09026931 | 666.700 | C28H38N6O11S | 0.000 | OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1 | 100mg | 335401182](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000130722.jpg-250.jpg)
eMolecules 171599-83-0 | Sildenafil citrate | Target Molecule | MFCD09026931 | 666.700 | C28H38N6O11S | 0.000 | OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1 | 100mg | 335401182
Sildenafil citrate | Target Molecule | 171599-83-0 | MFCD09026931 | 666.700 | C28H38N6O11S | 0.000 | OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1 | 100mg | 335401182
Medchemexpress LLC HY-112929 10mg Medchemexpress, DT-061 CAS:1809427-19-7 Purity:>98%
Medchemexpress, HY-112929 10mg DT-061 CAS:1809427-19-7 DT-061 is an orally bioavailable activator of protein phosphatase 2A (PP2A) and could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC IACS-13909 | 2160546-07-4 | 100.0% | 377.27 | 1 ML
IACS-13909 is a selective, potent, and orally active SHP2 allosteric inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. It demonstrates greater selectivity for SHP2 compared to other phosphatases, including SHP1. This inhibitor exhibits antitumor activities and inhibits MAPK pathway signaling in receptor tyrosine kinase (RTK)-dependent cancers.
- Selective, potent, and orally active SHP2 allosteric inhibitor
- IC50 of 15.7 nM and Kd of 32 nM for SHP2
- Greater selectivity for SHP2 compared to other phosphatases
- Exhibits antitumor activities
- Inhibits MAPK pathway signaling in RTK-dependent cancers
Accela Chembio Inc N-cyclopropyl 4-nitrophenylsulfonamide | 25g | 549476-61-1 | MFCD00458256 | 97+% | Shelf Life: 2520 Days | Regular
N-cyclopropyl 4-nitrophenylsulfonamide | 25g | 549476-61-1 | MFCD00458256 | 97+% | Shelf Life: 2520 Days | Regular
Medchemexpress LLC Sulfacetamide | 144-80-9 | 10 MM 1 ML
Sulfacetamide is a sulfonamide antibiotic used in topical formulations for ophthalmic, dermatological, and hair solutions. It targets bacterial folic acid synthesis and is effective against various gram-positive and gram-negative bacteria.
- Exhibits antifungal and antibacterial activities
- Used to treat bacterial infections, acne, and scalp conditions
- Targets bacterial folic acid synthesis
- Effective against various gram-positive and gram-negative bacteria
- Inhibits the synthesis of both dihydro-folic acid and para-aminobenzoic acid
- Can be utilized for studying ocular infections
Medchemexpress LLC YAP/TAZ inhibitor-1 | 2093565-23-0 | 99.7% | 621.81 | 10 MG
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor, extracted from patent WO2017058716A1, Compound 1. It has an IC50 of <0.100 μΜ in a firefly luciferase assay. As an inhibitor of transcriptional coactivator with PDZ binding motif/Yes-associated protein transcriptional coactivator (TAZ/YAP), it targets transcriptional co-activators of the Hippo pathway network, which regulate cell proliferation, migration, and apoptosis.
- Appearance: solid
- Color: off-white to yellow
- Shipping: room temperature in continental US; may vary elsewhere
- Storage (solid): 4°C, protect from light
- Storage (in solvent): -80°C for 6 months; -20°C for 1 month (protect from light)
Sigma Aldrich Fine Chemicals Biosciences Ribonucleic acid diethylaminoethanol salt Type IX | 63231-63-0 | MFCD00132195 | 5G
Ribonucleic acid diethylaminoethanol salt Type IX | 63231-63-0 | MFCD00132195 | 5G
Medchemexpress LLC 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid | 54-31-9 | MFCD00010549 | 100.0% | 330.74 | C12H11ClN2O5S | 10 MG
Furosemide reference standard is an analytical-grade reference material of the loop diuretic furosemide intended for research and analytical applications. It is provided as a 10 mg solid with high purity suitable for assay calibration, method development, and quality control in laboratories.
- High purity: 99.95%.
- CAS number: 54-31-9.
- Molecular formula: C12H11ClN2O5S.
- Molecular weight: 330.74.
- Pack size: 10 mg solid.
- Intended for analytical and research use as a reference standard.
eMolecules 1001415-32-2 | 1-(benzenesulfonyl)-4-bromo-1H-indazole | Pharmablock | MFCD22566216 | 337.190 | C13H9BrN2O2S | 97.000 | Brc1cccc2n(ncc12)S(=O)(=O)c1ccccc1 | 1g | 551134017
1-(benzenesulfonyl)-4-bromo-1H-indazole | Pharmablock | 1001415-32-2 | MFCD22566216 | 337.190 | C13H9BrN2O2S | 97.000 | Brc1cccc2n(ncc12)S(=O)(=O)c1ccccc1 | 1g | 551134017